跳至主要内容
临床试验/NL-OMON54554
NL-OMON54554招募中2 期

Mapping of Sentinel lymph node drainage Using SPECT/CT to tailor highly selective elective nodal irradiation in node-negative neck of patients with head and neck cancer - SUSPECT-2 - SUSPECT-2

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Newly diagnosed and histopathologically proven lateralized primary HNSCC,
  • T1-4N0-2b without midline involvement, originating at one side of the oral
  • cavity, oropharynx, larynx (except T1 glottic), and hypopharynx, and planned
  • for treatment with primary radiotherapy, chemo-radiotherapy or
  • immuno-radiotherapy in curative setting
  • Age >= 18 years
  • WHO performance status 0 or 1
  • Signed written informed consent

排除标准

  • Distant metastatic spread at the time of inclusion
  • Chemotherapy or surgery (for the present tumor), prior to inclusion
  • Previous radiation treatment in the head and neck region, for any reason
  • Previous neck dissection
  • Recurrent or second primary tumor in the head and neck region
  • Head and neck malignancies arising from skin, lip, nose, sinuses,
  • nasopharynx, salivary glands, thyroid gland or esophagus
  • Pregnancy or no active contraception for pre-menopausal women
  • Known hypersensitivity to iodine or nanocolloid injection
  • Having any condition (physical, mental, sociological) that interferes with
  • the informed consent procedure and follow-up schedules

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验